Filana Therapeutics, Inc. (NASDAQ:FLNA)
| Market Cap | 49.76M-49.8% |
| Revenue (ttm) | 0 |
| Net Income | -42.28M+65.7% |
| EPS | -0.87+65.9% |
| Shares Out | 48.31M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 93,354,692 |
| Open | 0.98 |
| Previous Close | 0.74 |
| Day's Range | 0.90 - 1.30 |
| 52-Week Range | 0.67 - 4.98 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 29, 2026 |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About FLNA
Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$FLNA stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in FLNA holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by FLNA's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
FLNA Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New FLNA patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to FLNA from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in FLNA
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $1.23M |
| VXFVanguard Extended Market ETF | $506.37K |
| VHTVanguard Health Care ETF | $120.49K |
Estimated from each fund’s disclosed top holdings × AUM
FLNA Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from FLNA’s recent data — informational, not investment advice